Michael Pulsipher

Pediatric Bone Marrow Failure Network (pBMFN)

National Institute of Child Health and Human Development · U54

Project lead · $479.6K · Boston Children's Hospital

Clinical and Mechanistic Studies Defining Optimal Preparative Approaches to Infants with IL2RG/JAK3/RAG1/RAG2 SCID: A Randomized Trial of Busulfan Dosage

National Institute of Allergy and Infectious Diseases · U01

PI · $3.2M · National Marrow Donor Program

A Phase III Randomized Trial Comparing Unrelated Donor Bone Marrow Transplantation with Immune Suppressive Therapy for Newly Diagnosed Pediatric and Young Adult Patients with Severe Aplastic Anemia

National Heart, Lung, and Blood Institute · UH3

PI · $2.1M · Boston Children's Hospital

Donor Health-Related Quality-of-Life and Physician Decision-Making in the Context of Haploidentical Hematopoietic Stem Cell Transplantation (HaploQOL)

National Heart, Lung, and Blood Institute · R01

PI · $1.9M · University of Pittsburgh at Pittsburgh

A Trial Comparing Unrelated Donor BMT With IST for Pediatric and Young Adult Patients With Severe Aplastic Anemia (TransIT, BMT CTN 2202)

Principal investigator · Active not recruiting · Phase 3

Boston Children's Hospital

KIR Favorable Mismatched Haplo Transplant and KIR Polymorphism in ALL/AML/MDS Allo-HCT Children

Principal investigator · Enrolling by invitation · Phase 2

Michael Pulsipher

Stem Cell Related Donor Safety Study

Principal investigator · Completed

Center for International Blood and Marrow Transplant Research

Tacrolimus and Methotrexate With or Without Sirolimus in Preventing Graft-Versus-Host Disease in Young Patients Undergoing Donor Stem Cell Transplant for Acute Lymphoblastic Leukemia in Complete Remission

Principal investigator · Completed · Phase 3

Children's Oncology Group